U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07375797) titled 'Fecal Microbiota Transplantation Intervention on Microbiota Composition and Insulin Sensitivity in Diabetes' on Jan. 12.
Brief Summary: The purpose of the trial is to investigate the effect of fecal microbiota transplantation versus placebo on glycemic metabolism and gut microbiota composition in people with type 2 diabetes.
Study Start Date: Feb., 2026
Study Type: INTERVENTIONAL
Condition:
Diabetes Mellitus Type 2
Fecal Microbiota Transplantation (FMT)
Oral Glucose Tolerance Test
Continuous Glucose Monitoring
Intervention:
OTHER: Fecal Microbial Transplantation
The capsules consists of approximately 50 grams of donor feces. ...